Enzyme vs Pundi X (New) — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Pundi X (New) trades at Rp1,291 (market cap Rp335,62M, Rp23,16M 24h volume). The key difference: Pundi X (New) is far larger — about 2.5× Enzyme's market cap, and Pundi X (New)'s supply is capped (258,4M / 258,5M PUNDIX (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Pundi X (New) for 20 Days on average.
| MLN | PUNDIX | |
|---|---|---|
Market Cap | Rp134,13M | Rp335,62M |
Volume (24h) | Rp104,56M | Rp23,16M |
Circulating Supply | 3,3M MLN | 258,4M / 258,5M PUNDIX (100%) |
Typical Hold Time | 29 Days | 20 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
PUNDIX is currently trading at Rp1,328 with a market cap of Rp343.88M, showing bearish technical signals across moving averages and oscillators. The token is trading near its pivot point of Rp1,327 with support at Rp1,315 and resistance at Rp1,341. With 100% of the maximum 258.5 million tokens in circulation and an average hold time of 20 days, the asset shows complete distribution but limited recent fundamental developments.
Overall outlook remains cautious with strong bearish technical indicators suggesting continued downward pressure. Key opportunities include potential bounce from support levels, while major risks involve low liquidity and the token's high volatility. Investors should monitor for any protocol updates or exchange developments that could impact price action.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Pundi X develops blockchain-based devices to revolutionize retail transactions. Its point-of-sale solution enables merchants and customers to make instant in-store payments using blockchain technology.
Read more on PUNDIX →